At a recent conference in Nairobi, the World Health Organisation came under
severe attack, especially because of a general suspicion by participants that
its policies are tailored to benefit "big guys" giant pharmaceutical
firms and because the health body had asked 18 companies across the world
to stop manufacturing monotherapies drugs based on artemisinin alone.
The East African